Capricor Therapeutics Reports Third Quarter 2016 Financial Results and Provides Corporate Update

Go back to Capricor Therapeutics Reports Third Quarter 2016 Financial Results and Provides Corporate Update

Capricor Therapeutics (CAPR) Misses Q3 EPS by 2c

November 11, 2016 6:10 AM EST

Capricor Therapeutics (NASDAQ: CAPR) reported Q3 EPS of ($0.29), $0.02 worse than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Capricor Therapeutics (CAPR) click here.

... More